Cargando…

297. Lactobacillus: Friend or Foe

BACKGROUND: Lactobacillus are low virulence commensal organisms which are commonly found in the human oral cavity, gastrointestinal and genitourinary tracts. Although Lactobacillus bacteremia (LB) is rare, evidence aggregating from case reports has implicated LB in several medical conditions. As suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwanyanwu, Chiemeziem, Shobayo, Anuoluwapo, Ghitan, Monica, Chapnick, Edward, Kuhn-Basti, Margaret, Lin, Yu Shia, Simon, Samuel, Li, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777954/
http://dx.doi.org/10.1093/ofid/ofaa439.340
_version_ 1783631024233644032
author Nwanyanwu, Chiemeziem
Shobayo, Anuoluwapo
Ghitan, Monica
Chapnick, Edward
Kuhn-Basti, Margaret
Lin, Yu Shia
Simon, Samuel
Li, Rosanna
author_facet Nwanyanwu, Chiemeziem
Shobayo, Anuoluwapo
Ghitan, Monica
Chapnick, Edward
Kuhn-Basti, Margaret
Lin, Yu Shia
Simon, Samuel
Li, Rosanna
author_sort Nwanyanwu, Chiemeziem
collection PubMed
description BACKGROUND: Lactobacillus are low virulence commensal organisms which are commonly found in the human oral cavity, gastrointestinal and genitourinary tracts. Although Lactobacillus bacteremia (LB) is rare, evidence aggregating from case reports has implicated LB in several medical conditions. As such, there is reason to suggest that the presence of these organisms in blood cultures may not be due to spurious contamination, but rather, indicative of clinically meaningful events capable of inducing serious illnesses. The purpose of this study is to characterize the risk factors, clinical significance and outcomes of patients with LB. METHODS: We retrospectively reviewed the medical records of patients presenting to a large urban teaching hospital between January 1, 2017 and December 31, 2018, who were found to have LB. Identified individuals were grouped into two mutually exclusive case categories: true LB cases or non-true cases (i.e., contamination). Individuals with ≥1 positive blood and were started on appropriate antibiotics were considered true cases. Those with positive cultures not started on appropriate antibiotics were considered contaminants. RESULTS: A total of 14 patients were identified during our study period, with majority considered true LB cases [71.4%; n = 10]. These 14 individuals were mostly males [64.2%; n = 9] and reported no use of Lactobacilli probiotics [78.6%; n = 11] or antacids [57.1%; n = 8]. On average, true LB cases were older (mean [SD]): 80.1 [±10.9]vs. 54.0 [±19.1] years) and required longer hospitalization (38.5 [(±27.6] vs. 8.0 [(±6.2] days) compared to non-LB cases, respectively. Among the 10 true LB cases, the suspected source of infection included gastrointestinal system [50%; n = 5], infective endocarditis [10%; n = 1], genitourinary system [10%; n = 1]; and could not be determined in 3 [30%] cases. Concurrent infection with candida and gastrointestinal microbes were noted in four (40%) of the true LB cases, respectively. Overall, five deaths were observed, with 4 [80%] occurring in true LB cases and one in a non-LB case. CONCLUSION: LB should not be dismissed as contaminants particularly in at-risk patients for LB, such as the elderly or immunocompromised individuals. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777954
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77779542021-01-07 297. Lactobacillus: Friend or Foe Nwanyanwu, Chiemeziem Shobayo, Anuoluwapo Ghitan, Monica Chapnick, Edward Kuhn-Basti, Margaret Lin, Yu Shia Simon, Samuel Li, Rosanna Open Forum Infect Dis Poster Abstracts BACKGROUND: Lactobacillus are low virulence commensal organisms which are commonly found in the human oral cavity, gastrointestinal and genitourinary tracts. Although Lactobacillus bacteremia (LB) is rare, evidence aggregating from case reports has implicated LB in several medical conditions. As such, there is reason to suggest that the presence of these organisms in blood cultures may not be due to spurious contamination, but rather, indicative of clinically meaningful events capable of inducing serious illnesses. The purpose of this study is to characterize the risk factors, clinical significance and outcomes of patients with LB. METHODS: We retrospectively reviewed the medical records of patients presenting to a large urban teaching hospital between January 1, 2017 and December 31, 2018, who were found to have LB. Identified individuals were grouped into two mutually exclusive case categories: true LB cases or non-true cases (i.e., contamination). Individuals with ≥1 positive blood and were started on appropriate antibiotics were considered true cases. Those with positive cultures not started on appropriate antibiotics were considered contaminants. RESULTS: A total of 14 patients were identified during our study period, with majority considered true LB cases [71.4%; n = 10]. These 14 individuals were mostly males [64.2%; n = 9] and reported no use of Lactobacilli probiotics [78.6%; n = 11] or antacids [57.1%; n = 8]. On average, true LB cases were older (mean [SD]): 80.1 [±10.9]vs. 54.0 [±19.1] years) and required longer hospitalization (38.5 [(±27.6] vs. 8.0 [(±6.2] days) compared to non-LB cases, respectively. Among the 10 true LB cases, the suspected source of infection included gastrointestinal system [50%; n = 5], infective endocarditis [10%; n = 1], genitourinary system [10%; n = 1]; and could not be determined in 3 [30%] cases. Concurrent infection with candida and gastrointestinal microbes were noted in four (40%) of the true LB cases, respectively. Overall, five deaths were observed, with 4 [80%] occurring in true LB cases and one in a non-LB case. CONCLUSION: LB should not be dismissed as contaminants particularly in at-risk patients for LB, such as the elderly or immunocompromised individuals. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777954/ http://dx.doi.org/10.1093/ofid/ofaa439.340 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Nwanyanwu, Chiemeziem
Shobayo, Anuoluwapo
Ghitan, Monica
Chapnick, Edward
Kuhn-Basti, Margaret
Lin, Yu Shia
Simon, Samuel
Li, Rosanna
297. Lactobacillus: Friend or Foe
title 297. Lactobacillus: Friend or Foe
title_full 297. Lactobacillus: Friend or Foe
title_fullStr 297. Lactobacillus: Friend or Foe
title_full_unstemmed 297. Lactobacillus: Friend or Foe
title_short 297. Lactobacillus: Friend or Foe
title_sort 297. lactobacillus: friend or foe
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777954/
http://dx.doi.org/10.1093/ofid/ofaa439.340
work_keys_str_mv AT nwanyanwuchiemeziem 297lactobacillusfriendorfoe
AT shobayoanuoluwapo 297lactobacillusfriendorfoe
AT ghitanmonica 297lactobacillusfriendorfoe
AT chapnickedward 297lactobacillusfriendorfoe
AT kuhnbastimargaret 297lactobacillusfriendorfoe
AT linyushia 297lactobacillusfriendorfoe
AT simonsamuel 297lactobacillusfriendorfoe
AT lirosanna 297lactobacillusfriendorfoe